Sign in Register

Correction: Hyperoxygenation Attenuated a Murine Model of Atopic Dermatitis through Raising Skin Level of ROS.

By PLOS One Editors · · 1 min read

Save

Notice of Republication

This article was republished on October 19, 2026 to correct the author list and remove Yeo Kyong Lee from the byline. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected article are provided here for reference.

Supporting information

Related articles

PubMed

Treatment Decision-Making Journey Map for Adults with Atopic Dermatitis: A Descriptive Qualitative Study.

Background Adults with atopic dermatitis frequently make treatment-related decisions about symptom management, treatment, self-care, and relapse prevention, but how these decisions unfold across the course of a chronic and relapsing disease remains insufficiently understood. Objective To map the treatment decision-making journey of adults with atopic dermatitis and identify stage-specific support needs from the patient perspective. Methods A descriptive qualitative study was carried out in...

PubMed

Dupilumab in Atopic Dermatitis - Rate of Poor Responders and Potential Risk Factors from the TREATgermany Registry.

A distinct proportion of patients with atopic dermatitis and dupilumab treatment does not reach the primary endpoint of an eczema area severity index (EASI)-75 or investigator global assessment 0/1 after 16 weeks. Little is known about poor responders to dupilumab in real life scenarios. The study objective was to identify the percentage and characteristics of patients with insufficient treatment response to dupilumab based on “TREATgermany” registry data from dermatological routine care. Betwee...